Login / Signup

Hispanic adults with type 2 diabetes mellitus using lipid-lowering agents have better periodontal health than non-users.

Oelisoa M AndriankajaKaumudi J JoshipuraMichael A LevineMargarita Ramirez-VickJulio A Rivas-AgostoJorge S DucongeDana T Graves
Published in: Therapeutic advances in chronic disease (2023)
minimal LLA use. This association was not present among people using LLA > 4 years users, but these participants had poorer glycemic control compared to other participants. In this cross-sectional study, the finding that LLA use 1- 4 years is associated with lower values of periodontal parameters of severity in T2D individuals may help clarify some of the controversies regarding the benefit of these medications in this population.
Keyphrases
  • glycemic control
  • type diabetes
  • blood glucose
  • healthcare
  • public health
  • weight loss
  • fatty acid
  • metabolic syndrome
  • risk assessment
  • health promotion
  • climate change
  • human health